Search - tctmd.com

Displaying 81 - 93 of 93

Sort: Relevancy | Date

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

Presentation TCT 2013

TCT-132. Prospective, Multicenter Tack Optimized Balloon Angioplasty (TOBA) Study for Femoropopliteal Arteries Using the Tack-IT Endovascular SystemTM

Presenter: Koen Deloose

October 28, 2013

Presentation TCT 2013

The Global Effect of Zilver PTX on Management of Femoropopliteal Disease

Presenter: Michael Dake

October 27, 2013

Presentation TCT 2013

Update on Percutaneous Femoropopliteal Bypass: The Next Evolutionary Step in SFA Treatment?

Presenter: James Joye

October 27, 2013

News Conference News TCT 2012

Aspirin, Cilostazol Combination Best After Angioplasty for Critical Limb Ischemia

November 01, 2012

Presentation TCT 2012

Femoropopliteal Atherectomy: A Critical Appraisal

Presenter: Lawrence Garcia

October 24, 2012

Presentation TCT 2012

TCT-585: Six-Month Results of the BIOLUX P-I First-in-Man Study Comparing a Paclitaxel-Releasing Balloon Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions

Presenter: Dierk Scheinert

October 23, 2012

Presentation TCT 2012

Tips and Tricks for Successful Crossing of Femoropopliteal CTOs

Presenter: Andrej Schmidt

October 23, 2012

News Conference News TCT 2012

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

October 23, 2012

Presentation TCT 2012

STOP-IC: A Prospective, Randomized Trial of Cilostazol after Endovascular Treatment of Femoropopliteal Lesions

Presenter: Hiroyoshi Yokoi

October 22, 2012

Presentation TCT 2012

The Pacifier Trial. A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal...

Presenter: Michael Werk, Thomas Albrecht, Dirk R. Meyer, Heiner Stiepani, Beatrix Schnorr, Enrique Lopez H?nninen

January 03, 2012

News Conference News

DEB Promising in Critical Limb Ischemia, Femoropopliteal Arterial Disease

November 08, 2011

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Kenneth Ouriel About LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease

September 26, 2019

Advertisement

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

TCT-132. Prospective, Multicenter Tack Optimized Balloon Angioplasty (TOBA) Study for Femoropopliteal Arteries Using the Tack-IT Endovascular SystemTM

The Global Effect of Zilver PTX on Management of Femoropopliteal Disease

Update on Percutaneous Femoropopliteal Bypass: The Next Evolutionary Step in SFA Treatment?

Aspirin, Cilostazol Combination Best After Angioplasty for Critical Limb Ischemia

Femoropopliteal Atherectomy: A Critical Appraisal

TCT-585: Six-Month Results of the BIOLUX P-I First-in-Man Study Comparing a Paclitaxel-Releasing Balloon Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions

Tips and Tricks for Successful Crossing of Femoropopliteal CTOs

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

STOP-IC: A Prospective, Randomized Trial of Cilostazol after Endovascular Treatment of Femoropopliteal Lesions

The Pacifier Trial. A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal...

DEB Promising in Critical Limb Ischemia, Femoropopliteal Arterial Disease

Dr. C. Michael Gibson Talks With Dr. Kenneth Ouriel About LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content